Inhibikase Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $93k | 58k | 1.62 |
| 2025-06-30 | $114k | 59k | 1.95 |